Observational studyJournal for immunotherapy of cancer2026
METLUNG: plasma metabolomic profiling identifies metabolomic signatures associated with immunotherapy outcomes in non-small cell lung cancer.
Clara Lucía-Gozálvez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.